How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,207 results for

Tongue Carcinoma

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1801. Royal Flying Doctor Service Western Operations Clinical manual part 1.Clinical guidelines

(Paediatric) 5 1.5 The Deteriorating Patient 7 2 CARDIOVASCULAR 1 2.1 Acute Coronary Syndromes 1 2.2 Acute Pulmonary Oedema 6 2.3 Cardiac Arrhythmias 8 3 ENDOCRINE 1 3.1 Diabetic Ketoacidosis 1 3.2 Hypoglycaemia 3 3.3 Hypocalcaemia 5 4 GASTROINTESTINAL 1 4.1 Acute Pancreatitis 1 4.2 Haematemesis and Melaena 3 4.3 Intestinal Obstruction 5 5 GENITOURINARY 1 5.1 Acute / Chronic Renal Failure 1 6 INFECTIOUS DISEASES 1 6.1 Bacterial Meningitis 1 6.2 Meningococcal Infection 3 6.3 Tuberculosis 5 6.4 Meliodosis 6 (...) controlled trial. The Lancet; Jun18-Jun24, 2005; 365, 9477 Fong N. Medical Emergency Response. Operational Directive OD 0040/07. Feb 2007. Department of Health Government of Western Australia.RFDS Western Operations Version 6.0 Clinical Manual Issue Date: January 2013 Part 1 - Clinical Guidelines Section 2 Page 1 Cardiovascular 2 CARDIOVASCULAR 2.1 Acute Coronary Syndromes Theory 1. Acute Coronary Syndromes (ACS) cover a broad spectrum of acute presentations of ischaemic heart disease. This guideline

2014 Clinical Practice Guidelines Portal

1802. Abuse and violence - working with our patients in general practice

apprehended domestic violence order AHPRA Australian Health Practitioner Regulation Agency AMA Australian Medical Association APVO apprehended personal violence order ASCA adults surviving child abuse ASP autism spectrum disorder CBT cognitive behavioural therapy FVO family violence order GBD global burden of disease GLBT gay, lesbian, bisexual, transgender GP general practitioner GRADE Grades of Recommendation, Assessment, Development and Evaluation IMG international medical graduate NATSISS National

2014 Clinical Practice Guidelines Portal

1803. Perinatal care at the threshold of viability

Oral (directly onto tongue) 0.25 mL (optimal dose uncertain) 78 Paracetamol 75 Oral 15 mg/kg every 6–8 hours Rectal Morphine 75 Oral 80–200 microgram/kg every 4 hours IV injection 50 microgram/kg every 4–6 hours Titrate dose as required SC injection IV infusion 10 microgram/kg/hour Fentanyl 75 Intranasal (via atomiser) 79 1.5 microgram/kg SC injection 1 microgram/kg every 2–4 hours IV injection IV infusion 1 microgram/kg/hour Titrate dose as required Midazolam 79 Intranasal 0.2–0.3 mg/kg Buccal IV

2014 Clinical Practice Guidelines Portal

1804. A Randomized Trial of Flattery

. But for most of us, a feedback sandwich is a lot like a tongue sandwich. People really feel: “Oh, feedback sandwich deli man, could I please just have the crisp, airy ciabatta? Hold the tongue.” That’s why I had Mr. Collins from Bio-Medical Engineering hang the height stick in my office 1.75 inches low. What’s the harm, really, if I tell my 5’6” patient that he’s 5’8”? Even if he gets challenged when he goes back to his neighborhood and starts telling people he’s 5’8”? His buddies may well say, “That’s (...) a lie! You’re 5’6”–tops!” But my patient can counter, “Oh yeah? My doctor measured me and he says I’m 5’8”!” I have tremendous admiration for many of my patients: the sisters who trade 12-hour shifts taking care of their 95-year-old mother, intensive care unit survivors with healed-over tracheotomy and feeding tube scars, people who have survived cancer, the loving parents of children with Down syndrome… To such patients I always say the following words: “I have tremendous admiration for you.” You

2014 Clinical Correlations

1805. HIV, viral hepatitis and STIs - a guide for primary care

– A GUIDE FOR PRIMARY HEALTH CARE iii HIV , VIRAL HEPATITIS & STIs A GUIDE FOR PRIMARY CARE 2014 EDITION EXPERT REFERENCE GROUP (EDITORIAL OVERSIGHT) Dr Michael Burke Nepean Sexual Health & HIV Clinic Ms Tracey Cabrie Victorian Infectious Diseases Service, Melbourne Health Associate Professor Ben Cowie Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, University of Melbourne Professor Greg Dore The Kirby Institute, UNSW Australia Dr Seamus Duffy Tuggerah Medical Centre Dr (...) , Tracey Cabrie, Benjamin Cowie, Gregory Dore, Seamus Duffy, Gail Matthews, Ronald McCoy, Anna McNulty, Simone Strasser, Catriona Ooi, David Youds and Iryna Zablotska COPY EDITOR Mary Sinclair PRINTED BY TTR Print Management INCLUDES INDEX HIV (Viruses) – Handbooks, manuals, etc. HIV infections – Handbooks, manuals, etc. Hepatitis, Viral – Handbooks, manuals, etc. Sexually transmitted diseases – Handbooks, manuals, etc. 616.9792 © Australasian Society for HIV Medicine Inc. 2014 ABN 48 264 545 457 CFN

2014 Clinical Practice Guidelines Portal

1806. Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis

immunocompromised Diabetic or have any other ongoing systemic condition deemed to be relevant by the local investigator-clinician Ongoing neoplastic disease other than localized basal cell or squamous cell carcinoma of the skin Have known asthma, physical urticaria or angioedema Have any current infectious condition Cognitive impairment to the extent that cannot follow simple commands Is pregnant Wounds or ulcers on the head or in the mouth or on the tongue Using sensitive electronic implantable medical device (...) . On an immunosuppressive or otherwise immunocompromised Have a decubitus ulcer stage III or higher or a decubitus ulcer of any stage that is worsening. Diabetic or have any other ongoing systemic condition, as deemed to be relevant by the local investigator-clinician Ongoing neoplastic disease other than localized basal cell or squamous cell carcinoma of the skin Have known asthma, physical urticaria or angioedema Have any current infectious condition Is pregnant No experience with computers or illiterate Using

2010 Clinical Trials

1807. Congenital angiomyoma of the tongue: case report Full Text available with Trip Pro

Congenital angiomyoma of the tongue: case report Angiomyomas of the oral cavity are rare benign vascular neoplasms. In particular, the congenital form has not been reported before in the English language literature. We present a congenital angiomyoma of the tongue that was found on the posterior middle of the tongue in an infant. On MRI, the mass showed an isointense signal to muscle on the T₁ weighted image and a slightly hyperintense signal on the T₂ weighted image. Immunohistochemically (...) , tumour cells were positive to desmin and smooth muscle actin, but negative to vimentin and S100. The treatment was surgical excision and no recurrence was found during the 26 month follow-up period.

2010 Dentomaxillofacial Radiology

1808. Hot tongue on FDG PET scan in a patient of Hodgkin’s lymphoma undergoing antipsychotic treatment Full Text available with Trip Pro

Hot tongue on FDG PET scan in a patient of Hodgkin’s lymphoma undergoing antipsychotic treatment Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography (F-18 FDG PET-CT) is the modality of choice for the diagnosis, staging, and restaging of many malignancies. The importance of eliminating false positives cannot be underestimated because they can dramatically alter the clinical course. We present a case of benign uptake in the tongue secondary to tardive dyskinesia

2010 Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

1809. A strategic approach for tongue reconstruction to achieve predictable and improved functional and aesthetic outcomes. (Abstract)

to T4 tongue cancers. The defects were classified prospectively into three groups: group A, hemiglossectomy defects (n=42) reconstructed with 33 radial forearm flaps and nine anterolateral thigh perforator flaps; group B, subtotal glossectomy defects (n=50) reconstructed with anterolateral thigh perforator (n=44) or anterolateral thigh myocutaneous flaps (n=6); and group C, total glossectomy defects (n=12) reconstructed with 12 pentagonal anterolateral thigh myocutaneous flaps.Two flaps failed (...) A strategic approach for tongue reconstruction to achieve predictable and improved functional and aesthetic outcomes. Successful tongue reconstruction should restore swallowing, speech function, and cosmesis. The purpose of this prospective study was to evaluate the functional and aesthetic outcomes of tongue reconstruction using variable free flaps based on different tongue defects.One hundred four patients with a mean age of 49±11 years underwent free tissue transfer following resection of T2

2010 Plastic and reconstructive surgery

1810. Tongue necrosis: a rare complication of oral intubation. Full Text available with Trip Pro

Tongue necrosis: a rare complication of oral intubation. (1) Present a unique case of partial necrosis of the dorsal tongue caused by an endotracheal tube; (2) highlight the importance of verifying proper endotracheal tube positioning during cases requiring prolonged intubation.Case report and literature review.A 50 year-old man underwent total thyroidectomy and bilateral lymphadenectomies for papillary thyroid carcinoma. A nerve monitoring endotracheal tube was used during the case (...) . Postoperatively, the patient reported tongue pain and examination revealed partial necrosis of his dorsal tongue. On follow up, the patient had improved tongue pain and well-healing dorsal tongue.We present the a case of tongue ischemia and partial necrosis due to oral endotracheal intubation, specifically with a nerve monitoring endotracheal tube, which has not previously been reported in the English literature. Tongue necrosis due to compression by an endotracheal tube during prolonged intubation is unusual

2010 Laryngoscope

1811. Differentiating between congenital rhabdomyosarcoma versus fibromatosis of the pediatric tongue. (Abstract)

Differentiating between congenital rhabdomyosarcoma versus fibromatosis of the pediatric tongue. Congenital rhabdomyosarcoma of the tongue is exceedingly rare. Fibromatosis of the tongue is also rare, and very difficult to distinguish from the spindle cell variant of rhabdomyosarcoma. Both appear histologically as spindle neoplasms replacing normal striated musculature of the tongue. The treatment protocol for the former has been developed by the Intergroup Rhabdomyosarcoma Studies (IRS) I-IV

2010 International Journal of Pediatric Otorhinolaryngology

1812. Schwannoma of the tongue in a child. Full Text available with Trip Pro

Schwannoma of the tongue in a child. Schwannomas are tumors of the peripheral nerves originating in the nerve sheaths that account for 1% of benign tumors located in the oral cavity. The tongue as a whole is the most common location for intraoral schwannomas to occur; however, it is quite rare to diagnose schwannoma in children. We are contributing a report of a 13-year-old child with a 1-year history of slowly growing swelling on the anterior part of corpus of the tongue. The patient

2010 American Journal of Otolaryngology

1813. "Burning tongue" and "burning tip": the diagnostic challenge of the burning mouth syndrome. (Abstract)

"Burning tongue" and "burning tip": the diagnostic challenge of the burning mouth syndrome. To investigate the clinical features of burning mouth syndrome (BMS) in a large cohort of patients and to correlate them with the results of tongue biopsy.We screened 98 patients complaining of oral burning pain for at least 6 months. Forty-two patients were excluded after screening for contact sensitivity to dental materials, food allergies, tongue injuries, malignancies, connective tissue and metabolic (...) disorders, oral infectious diseases, vitamin deficiencies, and other systemic diseases known to cause neuropathy. Fifty-six patients underwent neurologic examination and assessment of pain intensity, depression, anxiety, quality of sleep, and quality of life. Tongue biopsy with the quantification of epithelial nerve fibers (ENF) was performed in 51 patients.Compared with 9 healthy participants (4.13+/-1.85 SD), epithelial innervation density was significantly reduced in 38 patients (1.35+/-1.46 SD; P

2010 Clinical Journal of Pain

1814. Metastatic cutaneous carcinosarcoma to the tongue. (Abstract)

Metastatic cutaneous carcinosarcoma to the tongue. Carcinosarcoma is a rare malignant tumour composed of a mixture of carcinomatous and sarcomatous elements. Carcinosarcoma metastatic to the tongue is extremely rare. An 84-year-old woman presented with a rapidly growing mass on the tongue. She had a history of surgery for carcinosarcoma of the occipital skin 9 months before. An excisional biopsy of the tongue mass was performed, and the lesion was histopathologically diagnosed as carcinosarcoma (...) . PET after diagnosis showed multiple hot uptakes in the whole body. The patient died of the disease 2 months after diagnosis. Therapies for patients with metastatic malignant tumours to the oral cavity are difficult, especially in aggressive case such as this. To the authors' knowledge, this is the first case of metastatic carcinosarcoma to the tongue.Copyright © 2010 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

2010 International Journal of Oral and Maxillofacial Surgery

1815. Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer

compromising tumor coverage and/or increasing the dose to the remaining oral cavity or nearby parotid glands. Condition or disease Intervention/treatment Phase Head and Neck Cancer Radiation: Intensity Modulated Radiation Therapy Not Applicable Detailed Description: Using radiation dosimeter, we will perform measurement of the doses received by the mucosa adjacent to the dental fillings in patients receiving IMRT for head and neck cancer. If the mucosa dose is estimated to be greater than 35 Gy (...) Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer - Full Text View - Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2011 Clinical Trials

1816. Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer

No surgical resection of primary site or neck dissection (excisional biopsy of lymph node is permitted) Human Papilloma Virus (HPV) testing of tumor performed; HPV p16 by immunohistochemistry Stage III or IVa disease (T1-2N1-3M0, T3-4N0-3M0) excluding T1-2N1 oral cavity and tonsil primaries and any N2C or bilateral N3 disease. Patients with T2N0 cancer of the base of tongue and hypopharynx are eligible ECOG performance status 0-1 Age >18 years No current pregnancy No other invasive malignancies within (...) the last 2 years Patients with basal cell or squamous cell skin cancers or carcinoma in situ of any site are eligible. No prior radiotherapy to the head and neck region No prior cisplatin chemotherapy No symptomatic coronary disease or myocardial infarction within the last 6 months Laboratory evaluation: ANC > 2,000/mm3, platelets >100,000/mm3, creatinine < 1.5 mg/dl, creatinine clearance > 50 ml/min, bilirubin < 1.5 mg/dl, AST or ALT < 2X upper normal limit Study-specific consent signed prior to entry

2011 Clinical Trials

1817. Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

No multidrug resistance for HIV infection Not seropositive for hepatitis B (hepatitis B surface antigen positive or anti-hepatitis B core antigen positive) or hepatitis C (anti-hepatitis C antibody positive) Immunity to hepatitis B (anti-hepatitis B surface antibody positive) allowed No prior invasive malignancy except non-melanoma skin cancer, or malignancy for which the patient has been disease-free for at least 3 years (e.g., carcinoma in situ of the breast, oral cavity, or cervix) No severe, active co (...) , such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known whether radiation therapy is more effective with cisplatin or cetuximab in treating oropharyngeal cancer. PURPOSE: This phase III trial is studying radiation therapy with cisplatin or cetuximab to see how well it works in treating patients with oropharyngeal cancer. Condition or disease

2011 Clinical Trials

1818. A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients

Identifier: Other Study ID Numbers: APC-10U1101 First Posted: January 26, 2011 Last Update Posted: September 12, 2013 Last Verified: September 2013 Keywords provided by Access Pharmaceuticals, Inc.: Mucositis Head and Neck Cancer Squamous Cell Cancer Chemotherapy Radiation Therapy Oral Rinse Additional relevant MeSH terms: Layout table for MeSH terms Head and Neck Neoplasms Mucositis Stomatitis Neoplasms by Site Neoplasms Gastroenteritis Gastrointestinal Diseases Digestive System Diseases Mouth Diseases (...) of head and neck cancer are at high risk of developing oral mucositis as an adverse side-effect of cancer treatment. MuGard was previously shown to reduce the incidence and severity of mucositis in head and neck cancer patients undergoing radiation therapy when compared with data from historical control groups. The purpose of this study is to perform a direct comparison of the effectiveness of MuGard with a control group. Condition or disease Intervention/treatment Phase Oral Mucositis Device: MuGard

2011 Clinical Trials

1819. Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving combination chemotherapy together with cetuximab and erlotinib hydrochloride may kill more tumor cells. Condition or disease Intervention/treatment Phase Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma (...) ; persistent disease without clear-cut progression after radiotherapy can be considered measurable if biopsy-proven at least 8 weeks after completion of radiation therapy Patients with a prior history of squamous cell or basal carcinoma of the skin or in situ cervical cancer must have been curatively treated; patients with a history of other prior malignancy must have been treated with curative intent and must have remained disease-free for 3 years post diagnosis No current peripheral neuropathy > grade 2

2011 Clinical Trials

1820. French Biological Observatory on Lung Cancer in Never Smokers

or disease Lung Cancer Detailed Description: According to WHO, 25% of lung cancer worldwide occurs in lifelong never smokers. Lung cancer in never smokers (LCINS) shows many clinical, epidemiological, molecular and genomic differences comparing to tobacco-related neoplasm. So, it is now considered as a separate entity. LCINS particularly occurs in women and Asian. They are mainly adenocarcinoma. Known risk factors are occupational exposure, environmental tobacco smoking, familial history of cancer (...) Francophone de Cancerologie Thoracique: lung cancer smoking molecular epidemiology genetic polymorphism risk factors never smokers histologically/cytologically confirmed Additional relevant MeSH terms: Layout table for MeSH terms Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site Neoplasms Lung Diseases Respiratory Tract Diseases

2011 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>